The clinical suspicion of mosaicism justifies genetic testing for Legius syndrome and NF1, as now included in the newly formulated diagnostic criteria for the mosaic forms of both conditions (Legius et al. 2021). This evidence concerns the gene NF1 and Legius syndrome.